According to Vertex Pharmaceuticals, approximately 300 additional people with CF are now eligible to receive treatment.

The FDA on Fri­day is­sued two si­mul­ta­ne­ous cys­tic fi­bro­sis ap­provals for Ver­tex Phar­ma­ceu­ti­cals but in­clud­ed high-lev­el safe­ty warn­ings for both.

Separately, the FDA expanded the indication for Vertex's Trikafta on Friday to include cystic fibrosis patients with additional genetic variants. The FDA initially approved Trikafta in 2019 for ...

TRIKAFTA, a combination of elexacaftor, tezacaftor, and ivacaftor, is designed to enhance the function of the defective protein caused by cystic fibrosis transmembrane conductance regulator (CFTR) ...

Vertex Pharmaceuticals (VRTX) announced the U.S. Food and Drug Administration has approved the expanded use of Trikafta for the treatment of people with cystic fibrosis ages 2 and older who have ...

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved the expanded use of TRIKAFTA ® (elexacaftor ...

Vittoria hopes to meet with the FDA next year to discuss the work needed for a submission package for VIPER-102, the solid tumor therapy, and file an IND by either the end of next year or in early ...

Tis the season for holiday scams, and we've noticed one particular scam on the rise in 2024 that's now seen everywhere: Package and delivery scams. These tricks are especially hard to notice if ...

The Gmail package-tracking feature was first launched in 2022, allowing users to tap on an email to get a summary of a package's status, including when it was shipped and when it's expected to arrive.

generic versions of Trikafta, a particularly effective triple-combination treatment for the disease, which causes the body to produce thick, sticky mucus that damages the lungs and other organs.